PharmTech News

Articles

The company will launch a generic version of EpiPen at the price of $300 for a two-pack.

Mylan to Launch Generic Version of EpiPen

The initiative targets countries with less developed and evolving healthcare systems such as Latin America, South East Asia, and Africa.

Takeda Launches Medicines Access Strategy in Regions with High Unmet Medical Needs

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Ranking members of the Senate Judiciary Committee called on Mylan to explain its decision to raise the price of EpiPens nearly 400%.

Judiciary Committee Calls on Mylan to Explain EpiPen Price Increase

The portfolio in this agreement include approved antibiotics Merrem, Zinforo, and Zavicefta, as well as candidates in clinical development, ATM-AVI and CXL.

AstraZeneca Sells Antibiotics Business to Pfizer

Pfizer will acquire Medivation for approximately $14 billion.

Pfizer to Acquire Medivation

The legal battle between the Broad institute and UC Berkeley heated up after an email was released from a former graduate student.

The CRISPR Patent Debate

A KPMG survey reveals that approximately 84% of pharma and medical device executives plan to add jobs in next 12 months.

US Life Sciences CEOs Upbeat About Industry’s Prospects

Researchers at the ARC Centre of Excellence in Convergent Bio-Nano Science (CBNS) in Melbourne, Australia have developed a drug-delivery technology that circumvents first pas metabolism in the liver, thereby, enabling higher drug levels to reach the systemic circulation.

Exploiting Fat Absorption to Enhance Oral Bioavailability of Drugs

The NIH has launched a Phase I clinical trial in humans of an investigational Zika vaccine.

NIH Launches Zika Vaccine Clinical Trial

The investment will be spread across three sites: Barnard Castle in County Durham; Montrose, Scotland; and Ware, Hertfordshire.

Top News